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Additional Comments on Exposure Issues
in the NeonateArsenic, cadmium, lead, and aluminium (along with mer-
cury and manganese) form a suite of toxic metals affecting
the brain of exposed children. Although maternal exposure
to these toxicants occurs in combination, they are studied
mostly per se. Addressing early exposure to them in com-
bination is what makes the study of Chao et al1 unique and
timely. However, in view of recent research, comparatively
less attention was given to aluminium than to the other
studied elements.
While major sources of maternal exposure were dis-
cussed for Pb, As, and Cd, there was no indication as to the
sources of aluminum; nevertheless the authors advised
preventive strategies that included behavior modification
for “women who are at high risk of toxicant exposure”.
Although they recommended for not switching to formula
feeding as a means of abating exposure in general, there
was no mention that formulas, based on cow’s milk or soya,
are much higher in aluminium than is breast milk.2
They reported that aluminium concentrations were
highest in colostrums, at 56.45 ng/mL, decreasing to
36.57 ng/mL in transitional milk, and reaching the lowest
concentration in mature milk (13.44 ng/mL) of 60 to 65
days. Quite interestingly, they showed a significant
decrease with time of lactation, but did not discuss the fact
that formula feeding is constant in concentration and taken
in higher quantities than breast milk. In the nursing infant,
the exposure to aluminium in colostrum and breast milk is
proportional to the amount of milk nursed; it is taken in
smaller quantities (proportional to baby’s size) spread out
through the course of a day and during the entire lactation.
Another significant route of exposure to aluminium in
infants is through immunization with Al-adjuvanted vac-
cines where the addition to the body burden might be as
high as from breast milk or formula feeding.3 Indeed, the
first encounter a newborn (at day 0) has with aluminium is
not through colostrum but through a large parenteral load
of Al(OH)3 from the Hepatitis B vaccine (HBV) as anhttp://dx.doi.org/10.1016/j.pedneo.2014.03.001
1875-9572/Copyright ª 2014, Taiwan Pediatric Association. Published badjuvant. Indeed, neonates (<24 h and weighing > 2000 g)
may receive an Al (250 mg) exposure from HBV that is far in
excess of that absorbed from breast milk taken during the
entire six months of lactation.3
Rare neurologic adverse events or effects related to
adjuvant-Al are unlikely to occur as a result of HBV. However,
experimental studies modelling Al exposure relevant to vac-
cines have shown interesting results. Veiga et al4 recently
showed that young rats are susceptible to aluminium neuro-
toxicity, while Khan et al,5 demonstrated the translocation of
intramuscular injection of alum-adjuvanted vaccine from
muscle to brain. Indeed, adjuvant-Al from vaccines can pro-
duce neurological effects.6 Despite this new information on
Al exposure during early life, we still do not have reliable
measures of Al body loads in babies.2 However, in silico
modeling estimated that the Al body burden from feeding
(human milk and formulas) during the first year (0.1 mg) was
much less than that (4 mg) attributed to vaccines.7
Conflicts of Interest
The author has no conflicts of interest relevant to this article.
Jose´ G. Do´rea
Department of Nutrition, C.P. 04322, Faculty of Health
Sciences, Universidade de Brasilia,
70919-970 Brasilia, DF, Brazil
E-mail address: jg.dorea@gmail.com
Dec 11, 2013
References
1. Chao HH, Guo CH, Huang CB, Chen PC, Li HC, Hsiung DY,
et al. Arsenic, cadmium, lead, and aluminium concentrations
in human milk at early stages of lactation. Pediatr Neonatol
2014;55:127e34.y Elsevier Taiwan LLC. All rights reserved.
82 Editorial2. Exley C. Human exposure to aluminium. Environ Sci Process
Impacts 2013;15:1807e16.
3. Do´rea JG, Marques RC. Infants’ exposure to aluminum from
vaccines and breast milk during the first 6 months. J Expo Sci
Environ Epidemiol 2010;20:598e601.
4. Veiga M, Bohrer D, Bandero´ CR, Oliveira SM, do Nascimento PC,
Mattiazzi P, et al. Accumulation, elimination, and effects of
parenteral exposure to aluminum in newborn and adult rats. J
Inorg Biochem 2013;128:215e20.5. Khan Z, Combadie`re C, Authier FJ, Itier V, Lux F, Exley C, et al.
Slow CCL2-dependent translocation of biopersistent particles
from muscle to brain. BMC Med 2013;11:99.
6. Shaw CA, Li Y, Tomljenovic L. Administration of aluminium to
neonatal mice in vaccine-relevant amounts is associated with
adverse long term neurological outcomes. J Inorg Biochem
2013;128:237e44.
7. Keith LS, Jones DE, Chou CH. Aluminum toxicokinetics regarding
infant diet and vaccinations. Vaccine 2002;20:S13e7.
